Related Experiment Video
Updated: Dec 27, 2025

09:44
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
22.3K
Relationship Between Tau, β Amyloid and α-Synuclein Pathologies
Lauren Walker1, Johannes Attems2
1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. Lauren.walker1@ncl.ac.uk.
Advances in Experimental Medicine and Biology
|February 26, 2020
Summary
Multiple co-existing brain lesions in elderly individuals, including those with dementia, impact neurodegenerative disease progression. Understanding these protein aggregate interactions is crucial for predicting clinical outcomes in dementia.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Multiple pathological lesions frequently coexist in elderly brains, affecting both demented and non-demented individuals.
- Interactions between these lesions occur at the molecular level, contributing to cumulative brain damage.
- The presence of multiple protein aggregates is increasingly recognized as a significant factor in neurodegenerative diseases.
Purpose of the Study:
- To discuss the impact of multiple pathological lesions on the pathological and clinical phenotypes of neurodegenerative disorders.
- To explore the implications of co-existing lesions for dementia progression.
- To highlight the role of molecular interactions in disease manifestation.
Main Methods:
- Review of existing literature on neuropathology in aging and dementia.
- Analysis of studies investigating co-pathologies in neurodegenerative diseases.
- Discussion of molecular mechanisms underlying lesion interactions.
Main Results:
- Evidence suggests that the interplay of multiple lesions significantly influences the presentation and severity of neurodegenerative diseases.
- Cumulative effects of diverse pathological insults contribute to brain damage.
- The combination of lesions, rather than single pathologies, may better predict clinical outcomes.
Conclusions:
- The co-existence of multiple pathological lesions is a critical determinant of the clinical course in neurodegenerative disorders associated with dementia.
- Understanding these complex interactions is essential for accurate diagnosis and prognosis.
- Further research into the molecular basis of co-pathology is warranted to develop targeted therapies.
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.2K
6.2K
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

